Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shanghai Titan Scientific Co.,Ltd. (688133.SS)
CNY20.94
+1.54 (+7.94%)
CN SHH Basic Materials Chemicals
Address
No. 89, Shilong Road 200232
Shanghai, CN
Shanghai, CN
CEO
Qing Zhang
Website
titansci.com
IPO
2020-10-30
ISIN CNE100005XG3
Description
Shanghai Titan Scientific Co., Ltd. furnishes essential laboratory supplies and comprehensive support services tailored for scientists and quality assurance professionals. The company caters to diverse laboratory domains such as biomedical research, advanced materials, renewable energy, industrial chemistry, specialty chemicals, consumer product manufacturing, and analytical testing. It achieves this through a multifaceted approach, including proprietary product development, brand stewardship, strategic distribution agreements, and all-inclusive service packages. Founded in 2007, the company's main operations are based in Shanghai, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY20.94
+1.54 (+7.94%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
0.58
Float Shares
116.25M
Free Float %
70.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -9.69% | -20.29% | -2.00% | -12.52% | -3.97% | -0.63% | +0.82% | -56.93% | -80.99% | -34.72% | -34.72% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
20.94
DCF (Levered)
16.05
-23.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.13
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals: +4.0%-12.8% Q1'26: -3.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-337.5% Q1'26: -766.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.2% Q1'26: -28.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.0% Q1'26: -4.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%-0.7% Q1'26: -3.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+1.2% Q1'26: -5.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×57.23× Q1'26: -13.15× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.38B
est: 1.40B (-1.3%)
|
2.16B
est: 2.12B (+2.0%)
|
2.61B
est: 2.66B (-2.0%)
|
2.77B
est: 2.84B (-2.4%)
|
2.88B
est: 3.09B (-6.7%)
|
2.51B
est: 7.50B (-66.5%)
|
10.50B
10.50B – 10.50B
+40.0% YoY
|
14.17B
14.17B – 14.17B
+35.0% YoY
|
| EBITDA |
136.26M
est: 109.09M (+24.9%)
|
195.39M
est: 164.99M (+18.4%)
|
208.70M
est: 206.82M (+0.9%)
|
157.28M
est: 156.24M (+0.7%)
|
105.55M
est: 170.07M (-37.9%)
|
29.14M
est: 412.87M (-92.9%)
|
577.99M
577.99M – 577.99M
+40.0% YoY
|
780.26M
780.26M – 780.26M
+35.0% YoY
|
| EBIT |
126.30M
est: 83.73M (+50.8%)
|
179.51M
est: 126.63M (+41.8%)
|
181.40M
est: 158.74M (+14.3%)
|
116.95M
est: 115.07M (+1.6%)
|
51.59M
est: 125.26M (-58.8%)
|
-24.82M
est: 304.09M (-108.2%)
|
425.70M
425.70M – 425.70M
+40.0% YoY
|
574.68M
574.68M – 574.68M
+35.0% YoY
|
| Net Income |
102.76M
est: 108.43M (-5.2%)
|
143.95M
est: 162.22M (-11.3%)
|
124.81M
est: 139.76M (-10.7%)
|
72.57M
est: 26.67M (+172.2%)
|
12.89M
est: 96.20M (-86.6%)
|
-30.92M
est: 215.23M (-114.4%)
|
317.96M
317.96M – 317.96M
+47.7% YoY
|
440.25M
440.25M – 440.25M
+38.5% YoY
|
| SGA |
96.76M
est: 81.03M (+19.4%)
|
159.87M
est: 122.54M (+30.5%)
|
208.43M
est: 153.61M (+35.7%)
|
254.45M
est: 220.28M (+15.5%)
|
305.20M
est: 239.78M (+27.3%)
|
92.08M
est: 582.10M (-84.2%)
|
814.89M
814.89M – 814.89M
+40.0% YoY
|
1.10B
1.10B – 1.10B
+35.0% YoY
|
| EPS |
0.87
est: 0.66 (+30.8%)
|
0.96
est: 0.99 (-3.5%)
|
0.81
est: 0.86 (-5.5%)
|
0.44
est: 0.16 (+169.0%)
|
0.08
est: 0.59 (-86.4%)
|
-0.19
est: 1.32 (-114.4%)
|
1.95
1.95 – 1.95
+47.7% YoY
|
2.70
2.70 – 2.70
+38.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-541.62M
OE per share TTM
-3.30
Owner's Yield
-15.20%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
24.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 10 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 4.3K | 0.48% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 9.6K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 473.5K | 0.06% |
| 4 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 760.86 | 0.22% |
| 5 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.3K | 0.22% |
| 6 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.2K | 0.22% |
| 7 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 542.72 | 0.22% |
| 8 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 62.70 | 0.22% |
| 9 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 20.62 | 0.31% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 9.81 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-15.2K
Shares Outstanding
164.44M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fengyuan Xu | Deputy GM of Supply Center & Director | — | male |
| Gaoxiang Ding | Director, Deputy GM & Board Secretary | — | male |
| Hua Zhang | Deputy GM & Director | — | male |
| Jingyu Wang | Deputy GM & Director | — | male |
| Liang Gu | Chairman of the Supervisory Board & VP of Instrument Consumables Department | — | male |
| Qian Jing | Supervisor & Administrative Manager | — | female |
| Qing Zhang | GM, MD & Director | — | male |
| Sha Sha Chen | Operations Director | — | female |
| Wen Hui Ge | Technical Director of Research & Information Technology Department | — | male |
| Xiaowei Zhou | Vice President of Chemical Products | — | male |
| Zhihong Zhou | Accounting Supervisor & Financial Controller | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688133.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
